Categories: News

NextGen Healthcare Announces Date for 2022 Investor Event

ATLANTA–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of cloud-based, ambulatory-focused technology solutions, will host its 2022 Investor Event on Tuesday, May 3, 2022, at the Nasdaq MarketSite in New York City from 10:00 a.m. to 12:00 p.m. The meeting will be held in person, and in addition, the company will broadcast the event live.

Program highlights will include sessions led by the following key executives:

  • David Sides – President and Chief Executive Officer
  • Katie Chaffee – Chief Client Officer
  • Sri Velamoor – Chief Growth and Strategy Officer
  • Jamie Arnold – Chief Financial Officer

How to Participate

In order to participate, we ask all investors register using the following link: https://edge.media-server.com/mmc/p/sbo3bpwy or contact mscalo@nextgen.com.

For additional information about the event, supporting materials, and the live broadcast, please visit the NextGen Healthcare 2022 Investor Day site at https://investorevent22.nextgen.com/ or visit the NextGen Healthcare investor webpage on investor.nextgen.com. The presentation will be archived for 90 days.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of cloud-based ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better healthcare outcomes for all. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Contacts

Investor Relations Contact
Matthew Scalo

(415) 370-9202

mscalo@nextgen.com

Staff

Recent Posts

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…

9 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…

12 hours ago

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

12 hours ago

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

12 hours ago

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…

12 hours ago